Quinoline

Quinoline

SCHEMBL29354528

O=CO.c1ccc2ncccc2c1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.74
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CASP1 P29466 2/20 0.48
CASP7 P55210 1/20 0.48
NPC1 O15118 2/20 0.47
POLB P06746 2/20 0.47
RAB9A P51151 1/20 0.47
CYP3A4 P08684 2/20 0.45
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
NR4A2 P43354 1/20 0.44
TP53 P04637 1/20 0.44
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
TSHR P16473 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL4721637 1.00 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL28096081 1.00 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL28425004 0.98 ALDH1A1 (0.71) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL27889103 0.98 ALDH1A1 (0.71) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL28096623 0.89 ALDH1A1 (0.77) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL27700047 0.89 ALDH1A1 (0.85) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL27832156 0.87 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL27851343 0.87 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL27925298 0.87 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ACASP1CASP7
Quinoline SCHEMBL28166944 0.87 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ACASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11312713-B2 Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors PFIZER INC. (US) 2022-04-26 US disclosed
EP-3941459-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF Stingray Therapeutics, Inc. (US) 2022-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312713-B2 Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors LRRK2, PARK7, BRCA1 ALDH1A1 1569/4885MEN1 1387/4885KMT2A 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.